RE: 0.035 hit, could be EKG.v if FDA approve Hopefully it does. This stock has been stagnant for years after falling off a cliff in 08/09. The original intent of proving the out the THC alternate delivery method seems to have been lost in the new CEO's drive to "de-risk" (stupid mean-nothing buzz-word.) the subligual morphine delivery.
.045 today. wonder what is driving the price as nothing new out